Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CA and CO

Chief Financial Officer

Chief Executive Officer

Chief Medical Officer

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables, Florida.

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central ne...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-01-31	Premium	bought	Premium	Premium	Premium	CA and CO
2024-01-31	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2024-01-31	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2024-01-30	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2024-01-30	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2024-01-30	Premium	bought	Premium	Premium	Premium	CA and CO
2024-01-29	Premium	bought	Premium	Premium	Premium	CA and CO
2024-01-29	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2024-01-29	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2023-05-23	Premium	bought	Premium	Premium	Premium	Chief Medical Officer
2022-12-08	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2022-07-01	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2022-07-01	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2022-06-30	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2022-06-30	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2022-04-04	Premium	sold	Premium	Premium	Premium	-
2022-04-04	Premium	acquired	Premium	Premium	Premium	-
2022-04-01	Premium	acquired	Premium	Premium	Premium	-
2022-04-01	Premium	sold	Premium	Premium	Premium	-
2022-01-03	Premium	sold	Premium	Premium	Premium	-
2021-12-03	Premium	gifted	Premium	Premium	Premium	-
2021-12-03	Premium	gifted	Premium	Premium	Premium	-
2021-09-22	Premium	acquired	Premium	Premium	Premium	-
2021-09-22	Premium	sold	Premium	Premium	Premium	-
2021-08-17	Premium	acquired	Premium	Premium	Premium	-

RLMD - Relmada Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for RLMD